Y. Cao et al. / Tetrahedron 65 (2009) 2574–2578
2577
D
-glucopyranoside (1.32 g, 85%) as colorless oil. To a solution of
to afford unreacted 7 (79 mg, 32%) and 8 (152 mg, 64%) as a col-
25
ethylthio 2,4-di-O-allyl-3,6-di-O-benzyl- -glucopyranoside (936 mg,
b-D
orless syrup. [
(cmꢀ1): 3025, 2919, 2849, 1740, 1454, 1372, 1235, 1103, 1047, 741,
700; 1H NMR (400 MHz, CDCl3)
7.28–7.19 (m, 10H, Ph),
a
]
ꢀ26.3 (c 0.29, CHCl3); IR (thin film) nmax
D
1.93 mmol) in THF/H2O (2:1, 30 mL) at 0 ꢁC, solid NBS (1.00 g,
5.62 mmol) was added in small portions (ca. 10 mg every 2 min
interval). This procedure took 5 h. Then, solid Na2S2O3 was added
and THF was removed under vacuum. The mixture was extracted
with ethyl acetate and washed with brine. The concentrated
extract was purified by column chromatography (silica gel 30 g,
d:
5.63–5.61 (m, 2H, CH2CH]CHCH2), 5.06 (dt, J¼9.5, 2.8 Hz, 1H,
H-5), 4.96 (dd, J¼13.4, 5.0 Hz, 1H, CHaHCH]CHCH2), 4.72 (dd,
J¼14.8, 3.6 Hz, 1H, CH2CH]CHCHaH), 4.57 (d, J¼11.2 Hz, 1H, Bn),
4.50 (d, J¼11.2 Hz, 1H, Bn), 4.48 (d, J¼12.0 Hz, 1H, Bn), 4.42 (d,
J¼12.0 Hz, 1H, Bn), 4.19 (dd, J¼11.2, 7.7 Hz, 1H, H-1a), 4.04 (dd,
J¼11.2, 5.6 Hz, 1H, H-1b), 4.04–3.95 (m, 2H, CHHbCH]CHCHHb),
3.69 (d, J¼2.8 Hz, 2H, H-6), 3.68 (ddd, J¼7.7, 5.6, 1.2 Hz, 1H, H-2),
3.63 (dd, J¼9.5, 1.2 Hz, 1H, H-4), 3.53 (dd, J¼1.2, 1.2 Hz, 1H, H-3),
hexane/ethyl acetate¼9:1 to 3:1) to give 9 (4:1 anomeric mixture,
24
625 mg, 73%) as white crystals. Mp 89.5–91.0 ꢁC; [
a
]
þ50.6 (c
D
0.47, CHCl3); IR (thin film) nmax (cmꢀ1): 3385, 3029, 2920, 2855,
1725, 1645, 1539, 1454, 1360, 1269, 1090, 916, 745, 698; 13C NMR
(100 MHz, CDCl3)
d: 91.3 (d, C-1 of major isomer), 97.3 (d, C-1 of
1.97 (s, 3H, Ac), 1.94 (s, 3H, Ac); 13C NMR (100 MHz, CDCl3)
d:
minor isomer); ESIHRMS (m/z) [MþNaþ] calcd for C26H34O6
170.7 (s), 169.9 (s), 137.9 (s), 137.8 (s), 131.3 (d), 128.7 (d), 128.4 (d),
128.3 (d), 128.1 (d), 127.8 (d), 127.7 (d), 78.9 (d), 76.7 (d), 75.4 (d),
74.0 (t), 73.3 (t), 72.8 (d), 69.7 (t), 68.1 (t), 66.6 (t), 65.9 (t), 21.1
(q), 20.9 (q); ESIHRMS (m/z) [MþNaþ] calcd for C28H34O8
521.2151, found 521.2129.
463.2097, found 463.2094.
4.4. 1,5-Di-O-acetyl-2,4-di-O-allyl-3,6-di-O-benzyl-
D
-glucitol (7)
NaBH4 (300 mg, 7.89 mmol) was added to a solution of 9
4.6. 3,6-Di-O-benzyl-2,4-O-(Z-2-buten-1,4-yl)-D-glucitol (12)
(869 mg, 1.98 mmol) in ethanol (100 mL), and the mixture was
heated to reflux for 4 h. After cooling, ethanol was removed under
vacuum. Water was then added to the residue and the mixture was
extracted with ethyl acetate. The combined organic layer was
washed with brine. The concentrated extract was purified by col-
umn chromatography (silica gel 15 g, hexane/ethyl acetate¼2:1) to
Sodium methoxide (8.0 mg, 0.15 mmol) was added to the solu-
tion of 8 (152 mg, 0.305 mmol) in MeOH (10 mL), and the solution
was stirred for 24 h at ambient temperature. The mixture was
neutralized with Amberlite IR-120 (Hþ), filtered through a cotton
pad, and concentrated to give 12 as a colorless syrup (126 mg,
24
give 2,4-di-O-allyl-3,6-di-O-benzyl-
D
-glucitol (639 mg, 73%) as
-glu-
100%). [
a
]
ꢀ16.6 (c 0.96, CHCl3); IR (thin film) nmax (cmꢀ1): 3445,
D
colorless syrup. A mixture of 2,4-di-O-allyl-3,6-di-O-benzyl-
D
3029, 2920, 1651, 1454, 1356, 1101, 739, 698; 1H NMR (400 MHz,
citol (148 mg, 0.335 mmol), acetic anhydride (1 mL), and pyridine
(2 mL) was stirred for 4 h at room temperature. Then methanol
(2 mL) was added and the solution was stirred for additional
20 min. The excessive reagents were removed under vacuum. Then
1 M HCl was added and the solution was extracted with ethyl ac-
etate. The combined organic layer was successively washed with
H2O and brine. The concentrated extract was purified by column
CDCl3) d: 7.31–7.18 (m, 10H, Ph), 5.64–5.59 (m, 2H, CH2CH]CHCH2),
5.00 (dd, J¼13.6, 5.6 Hz, 1H, CHaHCH]CHCH2), 4.72 (dd, J¼16.0,
2.8 Hz, 1H, CH2CH]CHCHaH), 4.65 (d, J¼11.6 Hz, 1H, Bn), 4.59 (d,
J¼11.6 Hz, 1H, Bn), 4.50 (d, J¼11.6 Hz, 1H, Bn), 4.46 (d, J¼11.6 Hz, 1H,
Bn), 3.99 (dd, J¼13.6, 4.4 Hz, 1H, CHHbCH]CHCH2), 3.89 (dd,
J¼16.0, 2.4 Hz, 1H, CH2CH]CHCHHb), 3.85 (br s, 1H, H-2), 3.83
(ddd, J¼8.8, 4.6, 2.8 Hz, 1H, H-5), 3.73 (dd, J¼11.0, 8.8 Hz, 1H, H-6a),
3.64 (dd, J¼9.6, 2.8 Hz, 1H, H-4), 3.56–3.53 (m, 2H, H-1), 3.44 (dd,
J¼11.0, 4.6 Hz, 1H, H-6b), 3.24 (dd, J¼9.4, 1.0 Hz, 1H, H-3); 13C NMR
chromatography (silica gel 5 g, hexane/ethyl acetate¼3:1) to give 7
25
(164 mg, 93%) as a colorless syrup. [
a
]
D
þ4.0 (c 1.11, CHCl3); IR (thin
film) nmax (cmꢀ1): 3030, 2917, 2868, 1740, 1647, 1496, 1454, 1372,
(100 MHz, CDCl3) d: 138.5 (s), 137.7 (s), 131.6 (d), 128.5 (d), 128.5 (d),
1238, 1098, 739, 700; 1H NMR (400 MHz, CDCl3)
d
: 7.33–7.26 (m,
128.3 (d), 128.0 (d), 127.9 (d), 127.9 (d), 127.6 (d), 82.4 (d), 79.4 (d),
75.6 (d), 74.1 (t), 73.4 (t), 71.1 (t), 70.3 (d), 69.6 (t), 66.5 (t), 65.0 (t);
ESIHRMS (m/z) [MþNaþ] calcd for C24H30O6 437.1940, found
437.1938.
10H, Ph), 5.89 (dddd, J¼17.2, 6.0, 6.0, 2.8 Hz, 1H, OCH2CH]CH2),
5.87 (dddd, J¼17.2, 5.6, 5.6, 2.0 Hz, 1H, OCH2CH]CH2), 5.27–5.19
(m, 3H, OCH2CH]CH2 and H-5), 5.17–5.11 (m, 2H, OCH2CH]CH2),
4.65 (s, 2H, Bn), 4.52 (d, J¼12.0 Hz, 1H, Bn), 4.47 (d, J¼12.0 Hz, 1H,
Bn), 4.30 (dd, J¼12.0, 4.0 Hz, 1H, H-1a), 4.19 (dd, J¼12.0, 6.4 Hz,
1H, H-1b), 4.16–4.05 (m, 4H, OCH2CH]CH2), 3.85 (dd, J¼5.2, 4.8 Hz,
1H, H3), 3.83 (dd, J¼11.0, 3.6 Hz, 1H, H6a), 3.78 (ddd, J¼6.4, 5.2,
4.0 Hz, 1H, H2), 3.69 (dd, J¼11.0, 6.0 Hz, 1H, H6b), 3.68 (dd, J¼4.8,
4.8 Hz, 1H, H4), 2.04 (s, 3H, Ac), 2.00 (s, 3H, Ac); 13C NMR (100 MHz,
4.7. 3,6-Di-O-benzyl-2,4-O-(Z-2-buten-1,4-yl)-D-
glucopyranse (13)
A
solution of 12 (26 mg, 0.063 mmol) and IBX (52 mg,
CDCl3)
d
: 170.7 (s), 170.1 (s),138.0 (s), 137.9 (s), 134.7 (d), 128.4 (d),
0.19 mmol) in DMSO (2 mL) was stirred at ambient temperature for
24 h. After the addition of water, the mixture was filtered through
a cotton–Celite pad and the residue was washed with ethyl acetate.
The filtrate was extracted with ethyl acetate and the combined
organic layer was washed with brine. The concentrated extract was
purified by column chromatography (silica gel 6 g, hexane/ethyl
acetate¼5:1 to 2:1) to afford 13 (15.6 mg, 60%) as a colorless syrup,
together with recovered 12 (7 mg, 27%). IR (thin film) nmax (cmꢀ1):
3447, 3029, 2920, 2861, 1732, 1454, 1096, 739, 698; 1H NMR
128.3 (d), 128.3 (d), 127.7 (d), 127.6 (d), 117.4 (t), 116.9 (t), 78.2 (d),
78.2 (d), 76.7 (d), 74.6 (t), 73.4 (t), 73.2 (d), 73.1 (t), 72.2 (t), 68.2 (t),
64.1 (t), 21.1 (q), 20.9 (q); ESIHRMS (m/z) [MþNaþ] calcd for
C30H38O8 549.2464, found 549.2448.
4.5. 1,5-Di-O-acetyl-3,6-di-O-benzyl-2,4-O-(Z-2-buten-1,4-yl)-
D
-glucitol (8)
(400 MHz, CDCl3) d: 7.29–7.17 (m, 10H, Ph), 5.78–5.46 (m, 2H),
To a solution of 7 (250 mg, 0.475 mmol) in dried dichloro-
5.27–5.05 (m, 1H), 4.87–4.71 (m, 1H), 4.60–4.32 (m, 6H), 4.26–4.11
methane (400 mL) was added Grubbs first generation catalyst
(20 mg, 0.024 mmol), and then the solution was heated to reflux
for 12 h. Then the catalyst was further added (60 mg, 0.072 mmol)
in three portions every 12 h. The total reaction time was 48 h. The
solution was concentrated to 10 mL and subjected to column
chromatography (silica gel 25 g, hexane/ethyl acetate¼5:1 to 2:1)
(m, 1H), 3.81–3.56 (m, 5H), 3.47–3.44 (m, 1H), 2.91 (s, 1H, OH); 13C
NMR (100 MHz, CDCl3) d: 138.3 (s), 137.6 (s), 131.8 (d), 131.6 (d),
128.9 (d), 128.4 (d), 128.3 (d), 127.9 (d), 127.7 (d), 127.5 (d), 88.7 (d),
78.1 (d), 75.5 (d), 74.6 (d), 73.5 (t), 73.4 (t), 72.2 (t), 71.6 (t), 70.7 (d),
70.2 (t); ESIHRMS (m/z) [MþNaþ] calcd for C24H28O6 435.1784,
found 435.1782.